Aurinia Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $67,771 | $57,192 | $50,303 | $45,095 |
Gross Profit | 61,736 | 48,283 | 42,551 | 39,700 |
EBITDA | 20,908 | 4,402 | -3,880 | -15,651 |
EBIT | 16,015 | -441 | -8,727 | -20,600 |
Net Income | 14,350 | 722 | -10,749 | -26,875 |
Net Change In Cash | 67,771 | 57,192 | 50,303 | 45,095 |
Free Cash Flow | 16,900 | 15,779 | -18,609 | 14,765 |
Cash | 37,142 | 33,406 | 64,459 | 48,875 |
Basic Shares | 145,651 | 144,110 | 144,013 | 143,833 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $175,513 | $134,030 | $45,605 | $50,118 |
Gross Profit | 161,365 | 128,366 | 44,514 | -209 |
EBITDA | -63,047 | -108,764 | -177,445 | -102,919 |
EBIT | -74,694 | -111,470 | -180,206 | -104,290 |
Net Income | -78,020 | -108,180 | -180,966 | -102,680 |
Net Change In Cash | 175,513 | 134,030 | 45,605 | 50,118 |
Cost of Revenue | -40,450 | -33,669 | ||
Free Cash Flow | -34,179 | -79,821 | -159,193 | -77,201 |
Cash | 48,875 | 94,172 | 231,900 | 272,350 |
Basic Shares | 143,236 | 141,915 | 129,369 | 118,473 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.10 |
2024-06-30 | $0.01 |
2024-03-31 | -$0.03 |
2023-12-31 | -$0.19 |
